154 related articles for article (PubMed ID: 21127062)
1. Azadirachtin interacts with retinoic acid receptors and inhibits retinoic acid-mediated biological responses.
Thoh M; Babajan B; Raghavendra PB; Sureshkumar C; Manna SK
J Biol Chem; 2011 Feb; 286(6):4690-702. PubMed ID: 21127062
[TBL] [Abstract][Full Text] [Related]
2. Azadirachtin interacts with the tumor necrosis factor (TNF) binding domain of its receptors and inhibits TNF-induced biological responses.
Thoh M; Kumar P; Nagarajaram HA; Manna SK
J Biol Chem; 2010 Feb; 285(8):5888-95. PubMed ID: 20018848
[TBL] [Abstract][Full Text] [Related]
3. Suppression of IKK, but not activation of p53 is responsible for cell death mediated by naturally occurring oxidized tetranortriterpenoid.
Gupta P; Zaidi AH; Manna SK
J Cell Biochem; 2018 Aug; 119(8):6828-6841. PubMed ID: 29738082
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.
Jiménez-Lara AM; Aranda A; Gronemeyer H
Mol Cancer; 2010 Jan; 9():15. PubMed ID: 20102612
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors.
Rockel JS; Kudirka JC; Guzi AJ; Bernier SM
Arthritis Res Ther; 2008; 10(1):R3. PubMed ID: 18182117
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid induces interleukin-8 via the nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes.
Dai X; Yamasaki K; Shirakata Y; Sayama K; Hashimoto K
J Invest Dermatol; 2004 Dec; 123(6):1078-85. PubMed ID: 15610518
[TBL] [Abstract][Full Text] [Related]
7. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
9. The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.
Balasubramanian S; Fan M; Messmer-Blust AF; Yang CH; Trendel JA; Jeyaratnam JA; Pfeffer LM; Vestal DJ
J Biol Chem; 2011 Jun; 286(22):20054-64. PubMed ID: 21502320
[TBL] [Abstract][Full Text] [Related]
10. 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells.
Yadav VR; Prasad S; Gupta SC; Sung B; Phatak SS; Zhang S; Aggarwal BB
J Biol Chem; 2012 Jan; 287(1):245-256. PubMed ID: 22065587
[TBL] [Abstract][Full Text] [Related]
11. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
12. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.
Sethi G; Ahn KS; Aggarwal BB
Mol Cancer Res; 2008 Jun; 6(6):1059-70. PubMed ID: 18567808
[TBL] [Abstract][Full Text] [Related]
13. Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis.
Sethi G; Ahn KS; Sung B; Aggarwal BB
Mol Cancer Ther; 2008 Jun; 7(6):1604-14. PubMed ID: 18566231
[TBL] [Abstract][Full Text] [Related]
14. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice.
Austenaa LM; Carlsen H; Hollung K; Blomhoff HK; Blomhoff R
J Nutr Biochem; 2009 Sep; 20(9):726-34. PubMed ID: 18926686
[TBL] [Abstract][Full Text] [Related]
16. All-Trans Retinoic Acid Attenuates Transmissible Gastroenteritis Virus-Induced Inflammation in IPEC-J2 Cells
Pu J; Chen D; Tian G; He J; Huang Z; Zheng P; Mao X; Yu J; Luo J; Luo Y; Yan H; Yu B
Front Immunol; 2022; 13():734171. PubMed ID: 35173714
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid modulates ORMDL3 expression via transcriptional regulation.
Zhuang LL; Huang BX; Feng J; Zhu LH; Jin R; Qiu LZ; Zhou GP
PLoS One; 2013; 8(10):e77304. PubMed ID: 24204796
[TBL] [Abstract][Full Text] [Related]
18. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
19. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue.
Pandey MK; Sandur SK; Sung B; Sethi G; Kunnumakkara AB; Aggarwal BB
J Biol Chem; 2007 Jun; 282(24):17340-50. PubMed ID: 17439942
[TBL] [Abstract][Full Text] [Related]
20. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis.
Kunnumakkara AB; Ichikawa H; Anand P; Mohankumar CJ; Hema PS; Nair MS; Aggarwal BB
Mol Cancer Ther; 2008 Oct; 7(10):3306-17. PubMed ID: 18852134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
